Locoregional versus systemic therapy - robust positive data remain elusive

Nat Rev Clin Oncol. 2018 Sep;15(9):537-538. doi: 10.1038/s41571-018-0047-6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Hepatocellular*
  • Chemoembolization, Therapeutic*
  • Humans
  • Liver Neoplasms*
  • Neoplasm Recurrence, Local
  • Sorafenib

Substances

  • Sorafenib